Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25375206 | 0.98 | L3MBTL1 (0.65) | L3MBTL1MMP2NPC1RAB9AFFAR1 | |
| SCHEMBL38747 | 0.91 | PPARA (0.62) | L3MBTL1MMP2NPC1RAB9AFFAR1 | |
| SCHEMBL12099337 | 0.90 | PPARA (0.56) | L3MBTL1NPC1RAB9AFFAR1LMNA | |
| SCHEMBL16245586 | 0.89 | PPARA (0.63) | L3MBTL1NPC1RAB9AFFAR1PPARA | |
| SCHEMBL17265696 | 0.87 | PPARA (0.61) | L3MBTL1FFAR1PPARA | |
| SCHEMBL839412 | 0.87 | PPARA (0.61) | L3MBTL1FFAR1PPARA | |
| Hydrochloric Acid SCHEMBL830247 | 0.85 | PPARA (0.59) | L3MBTL1FFAR1PPARA | |
| SCHEMBL11288854 | 0.85 | L3MBTL1 (0.50) | L3MBTL1MMP2NPC1RAB9AFFAR1 | |
| SCHEMBL5191886 | 0.82 | TDP1 (0.52) | L3MBTL1NPC1RAB9ATSHRTDP1 | |
| SCHEMBL4842616 | 0.82 | FFAR1 (0.61) | L3MBTL1MMP2FFAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112062671-B | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2021-02-09 | — | — | CN | claimed |
| CN-112062671-A | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2020-12-11 | — | — | CN | claimed |
| US-4064129-A | Process for making quinacridone and its derivatives | HARMON COLORS CORPORATION (US) | 1977-12-20 | — | — | US | claimed |
| US-20230248837-A1 | Technology for Modulating Targeting Chimeras Induced by Cell-Penetrating Peptide and Application Thereof | LIU, MIAO (CN) | 2023-08-10 | — | — | US | disclosed |
| CN-112062671-B | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2021-02-09 | — | — | CN | disclosed |
| CN-112062671-A | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2020-12-11 | — | — | CN | disclosed |
| EP-2864289-B1 | CYCLOPROPANECARBOXAMIDO-SUBSTITUTED AROMATIC COMPOUNDS AS ANTI-TUMOR AGENTS | CB THERAPEUTICS INC (KY) | 2018-04-11 | — | — | EP | disclosed |
| EP-1246792-B1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECH INC (US) | 2014-08-13 | — | — | EP | disclosed |
| US-7977506-B2 | Amino acid for delivering active materials; bioavailability | EMISPHERE TECHNOLOGIES, INC. (US) | 2011-07-12 | — | — | US | disclosed |
| WO-2009117515-A2 | NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | AURIMMED PHARMA, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2008031034-A2 | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS | MYRIAD GENETICS, INC. (US) | 2008-03-13 | — | — | WO | disclosed |
| US-7151191-B2 | Compounds and compositions for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2006-12-19 | — | — | US | disclosed |
| EP-1246792-A4 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECH INC (US) | 2005-02-16 | — | — | EP | disclosed |
| US-20030149296-A1 | Compounds and compositions for delivering active agents | NOVO NORDISK NORTH AMERICA OPERATIONS A/S (DK) | 2003-08-07 | — | — | US | disclosed |
| EP-1246792-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | Emisphere Technologies, Inc. (US) | 2002-10-09 | — | — | EP | disclosed |
| WO-2001051454-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2001-07-19 | — | — | WO | disclosed |
| EP-0211326-B1 | PRODUCTION OF GRAVURE INKS FOR ILLUSTRATIONS | BAYER AG (DE) | 1990-06-06 | — | — | EP | disclosed |
| US-4739042-A | ESTERIFICATION OF AN HYDROXY PYRIDONE DYESTUFF WITH CARBOXYLIC PYRIDINE DYESTUFF | BAYER AKTIENGESELLSCHAFT (DE) | 1988-04-19 | — | — | US | disclosed |
| EP-0211325-A2 | Method of making heliographic and flexographic printing inks | BAYER AG (DE) | 1987-02-25 | — | — | EP | disclosed |
| EP-0211326-A2 | Production of gravure inks for illustrations | BAYER AG (DE) | 1987-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149296-A1 | Compounds and compositions for delivering active agents | SERPINB1, ELANE, MMP8 | L3MBTL1 3798/4885MMP2 162/4885NPC1 52/4885 |
| US-20230248837-A1 | Technology for Modulating Targeting Chimeras Induced by Cell-Penetrating Peptide and Application Thereof | VIP, GHITM, MYCBP | L3MBTL1 2113/4885MMP2 533/4885NPC1 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.